BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 36480452)

  • 1. Oxytocin at Elective Cesarean Delivery: A Dose-Finding Study in Pregnant People With Twin Pregnancy.
    Peska E; Balki M; Pfeifer W; Maxwell C; Ye XY; Downey K; Carvalho JCA
    Anesth Analg; 2024 Apr; 138(4):814-820. PubMed ID: 36480452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxytocin at elective caesarean delivery: a dose-finding study in women with obesity.
    Peska E; Balki M; Maxwell C; Ye XY; Downey K; Carvalho JCA
    Anaesthesia; 2021 Jul; 76(7):918-923. PubMed ID: 33227150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The ED90 of prophylactic oxytocin infusion after delivery of the placenta during cesarean delivery in laboring compared with nonlaboring women: an up-down sequential allocation dose-response study.
    Lavoie A; McCarthy RJ; Wong CA
    Anesth Analg; 2015 Jul; 121(1):159-164. PubMed ID: 25902327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carbetocin at Cesarean delivery for labour arrest: a sequential allocation trial to determine the effective dose.
    Nguyen-Lu N; Carvalho JC; Farine D; Seaward G; Ye XY; Balki M
    Can J Anaesth; 2015 Aug; 62(8):866-74. PubMed ID: 25860126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Up-down determination of the ED(90) of oxytocin infusions for the prevention of postpartum uterine atony in parturients undergoing Cesarean delivery.
    George RB; McKeen D; Chaplin AC; McLeod L
    Can J Anaesth; 2010 Jun; 57(6):578-82. PubMed ID: 20238255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxytocin requirements at elective cesarean delivery: a dose-finding study.
    Carvalho JC; Balki M; Kingdom J; Windrim R
    Obstet Gynecol; 2004 Nov; 104(5 Pt 1):1005-10. PubMed ID: 15516392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carbetocin at elective Cesarean delivery: a randomized controlled trial to determine the effective dose, part 2.
    Anandakrishnan S; Balki M; Farine D; Seaward G; Carvalho JC
    Can J Anaesth; 2013 Nov; 60(11):1054-60. PubMed ID: 24158878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of different infusion rates of oxytocin for maintaining uterine tone during elective caesarean section: A randomised double blind trial.
    Mohta M; Chowdhury RB; Tyagi A; Agarwal R
    Anaesth Intensive Care; 2021 May; 49(3):183-189. PubMed ID: 33934618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The ED
    Qian XW; Drzymalski DM; Lv CC; Guo FH; Wang LY; Chen XZ
    BMC Pregnancy Childbirth; 2019 Dec; 20(1):6. PubMed ID: 31892352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxytocin infusion for maintenance of uterine tone under prophylactic phenylephrine infusion for prevention of post-spinal hypotension in cesarean delivery: a prospective randomised double-blinded dose-finding study.
    Jin XQ; Shen YH; Fu F; Yu J; Xiao F; Huang XD
    BMC Pregnancy Childbirth; 2023 Dec; 23(1):840. PubMed ID: 38057742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effective Dose of Prophylactic Oxytocin Infusion During Cesarean Delivery in 90% Population of Nonlaboring Patients With Preeclampsia Receiving Magnesium Sulfate Therapy and Normotensives: An Up-Down Sequential Allocation Dose-Response Study.
    Tyagi A; Mohan A; Singh Y; Luthra A; Garg D; Malhotra RK
    Anesth Analg; 2022 Feb; 134(2):303-311. PubMed ID: 34469334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carbetocin at elective Cesarean delivery: a sequential allocation trial to determine the minimum effective dose.
    Khan M; Balki M; Ahmed I; Farine D; Seaward G; Carvalho JC
    Can J Anaesth; 2014 Mar; 61(3):242-8. PubMed ID: 24281981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minimum oxytocin dose requirement after cesarean delivery for labor arrest.
    Balki M; Ronayne M; Davies S; Fallah S; Kingdom J; Windrim R; Carvalho JC
    Obstet Gynecol; 2006 Jan; 107(1):45-50. PubMed ID: 16394038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbetocin at elective caesarean section: a sequential allocation trial to determine the minimum effective dose in obese women.
    Drew T; Balki M; Farine D; Ye XY; Downey K; Carvalho JCA
    Anaesthesia; 2020 Mar; 75(3):331-337. PubMed ID: 31867715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utilization of carbetocin for prevention of postpartum hemorrhage after cesarean section: a randomized clinical trial.
    Borruto F; Treisser A; Comparetto C
    Arch Gynecol Obstet; 2009 Nov; 280(5):707-12. PubMed ID: 19229549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous oxytocin dosing regimens for postpartum hemorrhage prevention following cesarean delivery: a systematic review and meta-analysis.
    Phung LC; Farrington EK; Connolly M; Wilson AN; Carvalho B; Homer CSE; Vogel JP
    Am J Obstet Gynecol; 2021 Sep; 225(3):250.e1-250.e38. PubMed ID: 33957113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carbetocin vs. oxytocin at elective caesarean delivery: a double-blind, randomised, controlled, non-inferiority trial of low- and high-dose regimens.
    McDonagh F; Carvalho JCA; Abdulla S; Cordovani D; Downey K; Ye XY; Farine D; Morais M; Balki M
    Anaesthesia; 2022 Aug; 77(8):892-900. PubMed ID: 35343585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxytocin infusion rates for maintaining uterine tone during non-elective cesarean section in laboring patients: a randomized, controlled trial.
    Mohta M; Siddiqui S; Chilkoti GT; Agarwal R
    J Anesth; 2022 Aug; 36(4):456-463. PubMed ID: 35484429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Randomized, Double-blinded Trial of a "Rule of Threes" Algorithm versus Continuous Infusion of Oxytocin during Elective Cesarean Delivery.
    Kovacheva VP; Soens MA; Tsen LC
    Anesthesiology; 2015 Jul; 123(1):92-100. PubMed ID: 25909969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of carbetocin for preventing postpartum bleeding after cesarean section in twin pregnancy.
    Sotillo L; De la Calle M; Magdaleno F; Bartha JL
    J Matern Fetal Neonatal Med; 2020 Jan; 33(2):267-271. PubMed ID: 30033782
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.